|
at 07:15 |
|
|
Dalan Animal Health, Inc. ("Dalan"), the leader in invertebrate health, today announced new experimental findings of their innovative bacterial vaccine's potential to significantly reduce Deformed Wing Virus variant B (DWV-B) in honeybee populations....
|
|
at 07:09 |
|
|
Essence SmartCare, part of Essence Group, a global leader in IoT remote care solutions, today announced the integration of Care@Home, an end-to-end senior care solution, with leading Swedish alarm management platform Skyresponse. Under this...
|
|
at 07:05 |
|
|
Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today announced highlights from presentations at the 15th European Epilepsy Congress (EEC) related to...
|
|
at 07:05 |
|
|
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the appointment of Mikael Dolsten, M.D., Ph.D., as an...
|
|
at 07:05 |
|
|
Ncardia, a leading human iPSC company, announced today the launch of a new panel of ready-to-use assays designed to streamline the screening and selection of new therapeutic candidates, with a specific focus on neurodegenerative diseases.
The new...
|
|
at 07:05 |
|
|
Following to the previous information on April 8th. 2024, we are excited to share our latest development status.
A Phase I/II clinical trial of DFP-10917 in combination with Venetoclax (VEN) in patients with acute myeloid leukemia (AML) who had one...
|
|
|
